ArticleEuropean journal of clinical investigation2021
A pilot study on the impact of congenital thrombophilia in COVID-19.
Abstract readLetter
In one paragraph
Article in European journal of clinical investigation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Functional, biochemical, and clinical characterization of natural mutations affecting arginine residues in the heparin-binding site of antithrombin.HemaSphere · 2026Article
- Autoantibodies to protein S may explain rare cases of coagulopathy following COVID-19 vaccination.Scientific reports · 2024Article
- Thrombophilia genetic mutations and their relation to disease severity among patients with COVID-19.PloS one · 2024Article
- A Rare Case of Pulmonary Embolism, Deep Vein Thrombosis, Bilateral Avascular Necrosis of the Femoral Head, and Miscarriage following COVID-19 in a Patient with Multiple Genetic Coagulation Factor Deficiency-A Case Report.Life (Basel, Switzerland) · 2023Article
- Protein S Deficiency and COVID-19: A Brutal Combination Leading to Acute Submassive Bilateral Pulmonary Embolism.Cureus · 2023Article
- Dermatological Manifestations in COVID-19: A Case Study of SARS-CoV-2 Infection in a Genetic Thrombophilic Patient with Mthfr Mutation.Pathogens (Basel, Switzerland) · 2023Article
- Role of Genetic Thrombophilia Markers in Thrombosis Events in Elderly Patients with COVID-19.Genes · 2023Article
- Inherited thrombophilia: undetected comorbidity complicating COVID-19 infection.American journal of blood research · 2023Article
- Thrombosis risk assessment in patients with congenital thrombophilia during COVID - 19 infection.Thrombosis research · 2022Article
- Hereditary Thrombophilia in the Era of COVID-19.Healthcare (Basel, Switzerland) · 2022Review
- Should we screen Eastern Mediterranean COVID-19 patients for inherited thrombophilia?Medical hypotheses · 2021Article
- A pilot study on the impact of congenital thrombophilia in COVID-19.European journal of clinical investigation · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Maria Eugenia de la Morena-BarrioServicio de Hematología y Oncología Médica, Centro Regional de Hemodonación, Hospital Universitario Morales Meseguer, Universidad de Murcia, IMIB-Arrixaca, CIBERER, Murcia, Spain.ORCID https://orcid.org/0000-0001-7426-4947
Carlos Bravo-PérezServicio de Hematología y Oncología Médica, Centro Regional de Hemodonación, Hospital Universitario Morales Meseguer, Universidad de Murcia, IMIB-Arrixaca, CIBERER, Murcia, Spain.ORCID https://orcid.org/0000-0001-9794-7847
Belen de la Morena-BarrioServicio de Hematología y Oncología Médica, Centro Regional de Hemodonación, Hospital Universitario Morales Meseguer, Universidad de Murcia, IMIB-Arrixaca, CIBERER, Murcia, Spain.ORCID https://orcid.org/0000-0002-6696-7762
Christelle OrlandoDepartment of Haematology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.ORCID https://orcid.org/0000-0003-2163-8778
Rosa CifuentesServicio de Hematología y Oncología Médica, Centro Regional de Hemodonación, Hospital Universitario Morales Meseguer, Universidad de Murcia, IMIB-Arrixaca, CIBERER, Murcia, Spain.
Jose PadillaServicio de Hematología y Oncología Médica, Centro Regional de Hemodonación, Hospital Universitario Morales Meseguer, Universidad de Murcia, IMIB-Arrixaca, CIBERER, Murcia, Spain.
Antonia MiñanoServicio de Hematología y Oncología Médica, Centro Regional de Hemodonación, Hospital Universitario Morales Meseguer, Universidad de Murcia, IMIB-Arrixaca, CIBERER, Murcia, Spain.
Sonia HerreroServicio de Hematología, Hospital General Universitario de Guadalajara, Guadalajara, Spain.
Shally MarcelliniServicio de Hematología, Hospital de Segovia, Segovia, Spain.
Nuria RevillaServicio de Hematología y Oncología Médica, Centro Regional de Hemodonación, Hospital Universitario Morales Meseguer, Universidad de Murcia, IMIB-Arrixaca, CIBERER, Murcia, Spain.
Enrique BernalSección de Enfermedades Infecciosas, Hospital Reina Sofía, Murcia, Spain.
Jose Miguel Gómez-VerdúServicio de Medicina Interna, Hospital Morales Meseguer, Murcia, Spain.
Kristin JochmansDepartment of Haematology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.
María Teresa HerranzServicio de Medicina Interna, Hospital Morales Meseguer, Murcia, Spain.
Vicente VicenteServicio de Hematología y Oncología Médica, Centro Regional de Hemodonación, Hospital Universitario Morales Meseguer, Universidad de Murcia, IMIB-Arrixaca, CIBERER, Murcia, Spain.
Javier CorralServicio de Hematología y Oncología Médica, Centro Regional de Hemodonación, Hospital Universitario Morales Meseguer, Universidad de Murcia, IMIB-Arrixaca, CIBERER, Murcia, Spain.ORCID https://orcid.org/0000-0003-0288-1107
María Luisa LozanoServicio de Hematología y Oncología Médica, Centro Regional de Hemodonación, Hospital Universitario Morales Meseguer, Universidad de Murcia, IMIB-Arrixaca, CIBERER, Murcia, Spain.
Funding
Fundación Séneca 00001/COVI/20Fundación Séneca 19873/GERM/15Instituto de Salud Carlos III CM20/00094Instituto de Salud Carlos III PI18/00598
Abstract
PubMed holds no abstract for this paper.
Indexed as
AdultAgedAntithrombin IIIAntithrombin III DeficiencyCohort StudiesCOVID-19Factor V DeficiencyFemaleFibrin Fibrinogen Degradation ProductsHumansHypoprothrombinemiasIntensive Care UnitsLogistic ModelsMaleMiddle AgedMortalityAntithrombin IIIFibrin Fibrinogen Degradation Productsfibrin fragment DPROS1 protein, humanProtein CProtein SSERPINC1 protein, human
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.